Back to top
more

Labcorp (LH)

(Real Time Quote from BATS)

$235.08 USD

235.08
51,710

+0.70 (0.30%)

Updated Nov 7, 2024 11:02 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 22% (54 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

LH vs. CNMD: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

LH vs. CNMD: Which Stock Is the Better Value Option?

Lower COVID-19 Testing Demand to Drag Abbott (ABT) Q2 Earnings

by Zacks Equity Research

Apart from COVIG-19 test related hiccups, Abbott (ABT) is likely to have suffered from significant sales decline within its pediatric nutrition business in Q2.

Integra's (IART) SurgiMend Gets Innovative Technology Contract

by Zacks Equity Research

Integra's (IART) SurgiMend Collagen Matrix is recognized as a product that can potentially bring improvement to the health care industry.

Trina Mukherjee headshot

3 Stocks to Tap the Promising Dental Supplies Industry

by Trina Mukherjee

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Thermo Fisher's (TMO) New Pact Drives Sustainable Lab Practices

by Zacks Equity Research

Thermo Fisher (TMO) expects to ACT label more than 1,200 additional SKUs to allow research, pharmaceutical and clinical laboratories to achieve their sustainability objectives.

Here's Why You Should Add Hill-Rom (HRC) to Your Portfolio

by Zacks Equity Research

Investors are optimistic about Hill-Rom (HRC) on robust international growth and raised 2021 outlook.

Thermo Fisher's (TMO) Rapid DNA Solution Gets FBI Approval

by Zacks Equity Research

Thermo Fisher's (TMO) RapidHIT ID DNA Booking System allows seamless integration of Rapid DNA into the law enforcement booking agency process.

Here's Why You Should Add LabCorp (LH) Stock to Your Portfolio

by Zacks Equity Research

Investors are optimistic about LabCorp (LH) backed by strong diagnostic arm growth and improvement in base business.

What Makes Align Technology (ALGN) a Solid Choice Right Now?

by Zacks Equity Research

Strong performance and latest innovations in the Invisalign and iTero family are driving the top line for Align Technology (ALGN).

LabCorp (LH) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Urmimala Biswas headshot

5 Lucrative Picks Based on PEG Ratio for GARP Investors

by Urmimala Biswas

Here are five out of the 10 stocks, ASO, LB, PTR, LH, and HIBB, based on hybrid GARP investment strategy.

LabCorp (LH) Expands Testing Portfolio With the Launch of CDx

by Zacks Equity Research

LabCorp's (LH) new test expands the company's leadership in bringing testing solutions for new precision medicines used to treat patients with lung cancer.

Myriad Genetics (MYGN) Divests Myriad RBM to Focus on Core Units

by Zacks Equity Research

Myriad Genetics' (MYGN) new divesture will enable company to accelerate the execution of transformation plan and drive growth.

Should Value Investors Buy LabCorp (LH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

LH vs. CNMD: Which Stock Is the Better Value Option?

by Zacks Equity Research

LH vs. CNMD: Which Stock Is the Better Value Option?

Pacific Biosciences (PACB)-RCIGM Tie Up for Sequencing Research

by Zacks Equity Research

Pacific Biosciences' (PACB) latest research tie-up is likely to use HiFi Sequencing data on some of the most difficult cases of rare pediatric disease and provide insights into the treatment journey.

Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

LabCorp (LH), Molecular Loop Team Up for COVID-19 Test Research

by Zacks Equity Research

The SARS-CoV-2 Research Sequencing Panel will help LabCorp (LH) sequence thousands of complete coronavirus genomes each week from positive patient samples.

LabCorp (LH) Boosts Precision Oncology With INSIGHT NGS Launch

by Zacks Equity Research

LabCorp (LH) enables evidence-based, personalized treatment suggestions based on the genomic profiling of a patient's solid tumor with the launch of new test.

LabCorp's (LH) Pixel Home Collection Kit Now in WBA Stores

by Zacks Equity Research

According to LabCorp (LH), the on-demand delivery option is useful for individuals showing symptoms of COVID-19 infection who want to be tested without potentially infecting others.

Riya Anand headshot

3 Medical Diagnostics Stocks in Focus on Long-Term Potential

by Riya Anand

MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.

Myriad Genetics (MYGN) Sells myPath to Focus on Core Units

by Zacks Equity Research

Myriad Genetics' (MYGN) new divesture will provide the company with growth capital for future investments.

Quest Diagnostics (DGX) New Pact Targets Health Inequity Issue

by Zacks Equity Research

Quest Diagnostics' (DGX) new collaboration with SAHRC will help improve the health and quality of lives of underserved communities.

LabCorp's (LH) New Bioanalytical Lab to Boost APAC Operation

by Zacks Equity Research

The new laboratory by LabCorp (LH) is set to enable faster data turnaround for early phase trials in Asia-Pacific markets.

LabCorp's (LH) Pixel Kit Gets EUA for Younger Population

by Zacks Equity Research

LabCorp (LH) becomes the first major commercial laboratory to offer a COVID-19 PCR Test Home Collection Kit for children and adolescents.